Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

| More on:
Overjoyed man celebrating success with yes gesture after getting some good news on mobile.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone right now:

Domain Holdings Australia Ltd (ASX: DHG)

According to a note out of Bell Potter, its analysts have upgraded this property listings company's shares to a buy rating with an improved price target of $3.30. This follows the release of a half year result which revealed a 27% increase in earnings per share. This was ahead of the market's expectations. The broker believes that this shows that Domain is repairing the damage to its audience and listings. It feels this could mean it is approaching the start of a potential consensus earnings upgrade cycle. The Domain share price is trading at $3.07 on Friday afternoon.

Pro Medicus Limited (ASX: PME)

Another note out of Bell Potter reveals that its analysts have upgraded this health imaging technology company's shares to a buy rating with an vastly improved price target of $330.00. This follows the release of another strong result from Pro Medicus this week. Bell Potter highlights that its full stack solution continues to wipe the floor with competitors. It notes that there have been 10 contract announcements in the last 12 months, including two new academic medical centres clients. The broker also notes that it expects further growth in the cardiology space with the first small scale implementation to take place in April. The Pro Medicus share price is fetching $284.80 at the time of writing.

Treasury Wine Estates Ltd (ASX: TWE)

Analysts at Goldman Sachs have retained their buy rating on this wine giant's shares with a slightly trimmed price target of $12.90. According to the note, the broker has reduced its sales and earnings forecasts slightly through to FY 2027 to reflect stronger Penfolds and Americas sales, offset by weaker Premium Brands sales. Outside this, Goldman points out that Treasury Wine's shares are trading on an FY 2026 P/E of just ~15x, which is inexpensive relative to its consumer coverage. And if it is able to demonstrate added comfort to the market on its Penfolds channel sell-through and sustained US luxury portfolio growth, it expects the stock to re-rate positively. The Treasury Wine share price is trading at $10.86 this afternoon.

Motley Fool contributor James Mickleboro has positions in Pro Medicus and Treasury Wine Estates. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus and Treasury Wine Estates. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man sits thoughtfully on the couch with a laptop on his lap.
Broker Notes

Why Macquarie forecasts this ASX All Ords media company is set to surge 19%

Up 42% in 2025, here’s why this ASX All Ords media stock could keep racing higher into 2026.

Read more »

Excited couple celebrating success while looking at smartphone.
Broker Notes

Buy this ASX 200 stock for a 50% return: Bell Potter

Let's see why the broker is bullish on this name.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Leading broker tips 50%+ upside for IDP Education shares

The team at Macquarie thinks this beaten down stock could be a buy.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Broker Notes

Bell Potter names the best ASX 200 stocks to buy in June

The broker is feeling bullish on these names this month. Let's find out why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Bell Potter says this ASX 200 share can rise 25%

Let's see what the broker is saying about this stock.

Read more »

Stethoscope with a piggy bank in the middle.
Broker Notes

Australian health insurance: Does Macquarie prefer Medibank or NIB shares?

Medibank and NIB shares have both surged in 2025. Here’s what Macquarie expects now.

Read more »

Man smiling at a laptop because of a rising share price.
Broker Notes

9 ASX 200 shares just upgraded to strong buy ratings

Brokers have upgraded these shares amid expectations of price growth over the next 12 months.

Read more »